241 related articles for article (PubMed ID: 33796097)
21. COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.
Latini A; Agolini E; Novelli A; Borgiani P; Giannini R; Gravina P; Smarrazzo A; Dauri M; Andreoni M; Rogliani P; Bernardini S; Helmer-Citterich M; Biancolella M; Novelli G
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32867305
[TBL] [Abstract][Full Text] [Related]
22. Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.
Zhang C; Verma A; Feng Y; Melo MCR; McQuillan M; Hansen M; Lucas A; Park J; Ranciaro A; Thompson S; Rubel MA; Campbell MC; Beggs W; Hirbo J; Wata Mpoloka S; George Mokone G; ; Nyambo T; Wolde Meskel D; Belay G; Fokunang C; Njamnshi AK; Omar SA; Williams SM; Rader DJ; Ritchie MD; de la Fuente-Nunez C; Sirugo G; Tishkoff SA
Proc Natl Acad Sci U S A; 2022 May; 119(21):e2123000119. PubMed ID: 35580180
[TBL] [Abstract][Full Text] [Related]
23. Gene expression network analysis provides potential targets against SARS-CoV-2.
Hernández Cordero AI; Li X; Yang CX; Milne S; Bossé Y; Joubert P; Timens W; van den Berge M; Nickle D; Hao K; Sin DD
Sci Rep; 2020 Dec; 10(1):21863. PubMed ID: 33318519
[TBL] [Abstract][Full Text] [Related]
24. Evidence for CAT gene being functionally involved in the susceptibility of COVID-19.
Qian Y; Li Y; Liu X; Yuan N; Ma J; Zheng Q; Liu F
FASEB J; 2021 Apr; 35(4):e21384. PubMed ID: 33710662
[TBL] [Abstract][Full Text] [Related]
25. Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2.
Shaker MR; Slonchak A; Al-Mhanawi B; Morrison SD; Sng JDJ; Cooper-White J; Khromykh AA; Wolvetang EJ
Sci Adv; 2024 Jun; 10(23):eadj4735. PubMed ID: 38838150
[TBL] [Abstract][Full Text] [Related]
26. Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability.
Guilger-Casagrande M; de Barros CT; Antunes VAN; de Araujo DR; Lima R
Front Cell Infect Microbiol; 2021; 11():598875. PubMed ID: 33791232
[TBL] [Abstract][Full Text] [Related]
27. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.
Hashemi SMA; Thijssen M; Hosseini SY; Tabarraei A; Pourkarim MR; Sarvari J
Arch Virol; 2021 Aug; 166(8):2089-2108. PubMed ID: 33934196
[TBL] [Abstract][Full Text] [Related]
28. Novel genetic association of the Furin gene polymorphism rs1981458 with COVID-19 severity among Indian populations.
Pandey RK; Srivastava A; Mishra RK; Singh PP; Chaubey G
Sci Rep; 2024 Apr; 14(1):7822. PubMed ID: 38570613
[TBL] [Abstract][Full Text] [Related]
29. Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom.
Kerslake R; Hall M; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Mol Med; 2020 Sep; 46(3):949-956. PubMed ID: 32705281
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Spike Targets USP33-IRF9 Axis
Mishra R; Banerjea AC
Front Immunol; 2021; 12():656700. PubMed ID: 33936086
[TBL] [Abstract][Full Text] [Related]
31. In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.
Gao J; Lei P; Su X; Liang J; Ren B; Ma X; Zhang Y; Zhang Y; Ma W
Phytomedicine; 2024 Jul; 129():155582. PubMed ID: 38608595
[TBL] [Abstract][Full Text] [Related]
32. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
Wang Z; He Y; Huang J; Yang X
Sci Rep; 2021 May; 11(1):10763. PubMed ID: 34031435
[TBL] [Abstract][Full Text] [Related]
33. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
Glinsky GV
Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
[TBL] [Abstract][Full Text] [Related]
34. The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis.
Huang X; Liang H; Zhang H; Tian L; Cong P; Wu T; Zhang Q; Gao X; Li W; Chen A; Zhang Y; Dong Q; Wan H; He M; Dai D; Li Z; Xiong L
Front Immunol; 2021; 12():804387. PubMed ID: 35082790
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223
[TBL] [Abstract][Full Text] [Related]
36. Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis.
Xia J; Chen S; Li Y; Li H; Gan M; Wu J; Prohaska CC; Bai Y; Gao L; Gu L; Zhang D
Front Immunol; 2022; 13():798538. PubMed ID: 35185890
[TBL] [Abstract][Full Text] [Related]
37. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
De Toma I; Dierssen M
Sci Rep; 2021 Jan; 11(1):1930. PubMed ID: 33479353
[TBL] [Abstract][Full Text] [Related]
38. The risk of pancreatic adenocarcinoma following SARS-CoV family infection.
Ebrahimi Sadrabadi A; Bereimipour A; Jalili A; Gholipurmalekabadi M; Farhadihosseinabadi B; Seifalian AM
Sci Rep; 2021 Jun; 11(1):12948. PubMed ID: 34155232
[TBL] [Abstract][Full Text] [Related]
39. Role of NRF2 and Sirtuin activators in COVID-19.
Khan H; Patel S; Majumdar A
Clin Immunol; 2021 Dec; 233():108879. PubMed ID: 34798239
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility to COVID-19 in populations with health disparities: Posited involvement of mitochondrial disorder, socioeconomic stress, and pollutants.
Yao Y; Lawrence DA
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22626. PubMed ID: 32905655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
